[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370107-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-370107-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","predisposition-of-an-intronic-duplication-in-chek2-gene-in-the-cases-of-breast-cancer-from-balochistan","Predisposition of an Intronic Duplication in CHEK2 Gene in the Cases of Breast Cancer from Balochistan","","Study evaluates germline CHEK2 variants and their association with breast cancer in the Balochistani population, following BRCA1/2 as the most common predisposing altered genes. Breast cancer cases and controls were analyzed using DNA sequencing and bioinformatics tools including Chromas, BLAT, and RNAfold. An intronic CHEK2 duplication variant c.319+38-43dupA was detected in 9% of cases and was linked to invasive ductal carcinoma. Higher tumor grade (III) and advanced stage were frequent; RNA predictions suggest miRNA coding potential in cancer progression.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/predisposition-of-an-intronic-duplication-in-chek2-gene-in-the-cases-of-breast-cancer-from-balochistan/370107/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/predisposition-of-an-intronic-duplication-in-chek2-gene-in-the-cases-of-breast-cancer-from-balochistan/370107.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What was the objective of the study on CHEK2 and breast cancer?","Question",{"text":62,"@type":63},"To analyze germline CHEK2 variants and determine their association with breast cancer in the Balochistani population.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How were CHEK2 variants identified in breast cancer patients and controls?",{"text":67,"@type":63},"DNA samples from registered cases were sequenced and analyzed using Chromas software and bioinformatics tools including BLAT and RNAfold.",{"name":69,"@type":60,"acceptedAnswer":70},"Which intronic CHEK2 variant was reported, and in how many cases?",{"text":71,"@type":63},"The intronic variant c.319+38-43dupA was identified, present in 9% of breast cancer cases and reported previously in non-Hodgkin lymphoma cases.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},370107,1790186750,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":96,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":79,"read_time":143,"preview_page_count":33,"preview_urls":144},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:01/02/2025 Acceptance:11/15/2025 Published:11/21/2025 |\n| --- | --- |\n\nPredisposition of an Intronic Duplication in CHEK2 Gene in the Cases of Breast Cancer from Balochistan  \nAbdul Hameed Baloch1 *, Jamila Shuja1, Nasrullah Bangulzai1, Mohammad Jan1, Abdul Sattar1, Sarfaraz Ahmed Brohi1, Habibullah Habibullah1, Dost Muhammad Baloch1, Jamil Ahmad2  \nAbstract  \nObjective: After BRCA 1&2, CHEK2 is the most frequently predisposing altered gene causing breast cancer in female. The prime objective of the current study was to analyze germline CHEK2 variants and their association with breast cancer in Balochistani population. Methods: Breast cancer is among the most prevalent cancers worldwide and most common diagnosed cancer in women. Mutations in many proto-oncogenes and tumor suppressor genes lead to the development of cancer. Along with the highly penetrance genes BRCA1 and BRCA2 increase the risk of breast cancer, mutations in other genes including CHEK2, a tumor suppressor gene have also been reported to be associated with breast cancer. In current study CHEK2 gene was analyzed for variation in breast cancer patients and controls of Balochistani population. Sequencing results of the DNA samples ofthe registered cases of breast cancer in CENAR were analyzed using Chromas software and bioinformatics tools including BLAT and RNAfold web server. Results: An intronic variant c.319+38-43dupA falling 38 nucleotide away at splice donor site of the CHEK2 gene exon 2, in 9% breast cancer cases, was identified which has also been previously reported in non-Hodgkin Lymphoma cases. All the cases with identified variant, were affected with invasive ductal carcinoma. Higher tumor grade (III) was reported in >50% of the patients and > 70% of patients diagnosed with advanced stage of cancer. The RNA prediction results revealed the variant falling in the intronic region may code for miRNA that could play an important role in cancer progression. Conclusion: Our results suggest that the intronic variant identified in breast cancer cases as well as reported previously may act as a cancer marker and causing a splice site disruption or altering the posttranscriptional modification of mRNA encoded by CHEK2 gene.  \nKeywords: Intron-Variant-Ethnic-Stage-Grade  \nAsian Pac J Cancer Prev, 26 (11), 3975-3979  \nIntroduction  \nBreast cancer, a global health concern, is a complex disease resulting from diverse lifestyle and genetic risk factors [1]. It is among the most highly prevalent cancers accounting~1 in every 8 cancer cases diagnosed and isthe most common cancer being diagnosed in women with a growing prevalence worldwide particularly in developing countries [2, 3] . It accounts 1 in every 6 cancer deaths in women globally [4, 5] . The occurrence of breast cancer is even worldwide but the rates of incidence, survival and mortality are considerably varying associated with the population structures, environmental, lifestyle and genetic factors.  \nThe survival rate from breast cancer being reported has improved in past 2-3 decades with even a high incidence rate whereas in various localities high mortality rate  \nhas also been reported that indicate a diverse pattern of breast cancer incidences worldwide [4, 6]. Various factors causing sporadic and hereditary mutations in many tumorsuppressor and proto-oncogenes influence the occurrence to breast cancer. The highly penetrance genes involved in increasing the risk of breast cancer are BRCA1 and BRCA2 with ~50% of the hereditary breast cancer cases whereas mutations in other genes including ATM, TP53, BRIP1, CHEK2, CDH1, PALB2 and other low penetrance genes also increase the risk of breast cancer [7] .  \nThe CHEK2 gene (ENST00000382580.6) located on 22q12.1 (Figure 1) coding for checkpoint kinase 2 (a human Cds-1 related kinase) that response to DNA damage, activated through phosphorylation by ataxia telangiectasia mutated (ATM) gene, resulting in modifi","cbCaipuqyXtdtDWO","https://ap.wps.com/l/cbCaipuqyXtdtDWO","pdf",655537,"English","# Abstract\n# Introduction\n# Materials and Methods","[{\"question\":\"What was the objective of the study on CHEK2 and breast cancer?\",\"answer\":\"To analyze germline CHEK2 variants and determine their association with breast cancer in the Balochistani population.\"},{\"question\":\"How were CHEK2 variants identified in breast cancer patients and controls?\",\"answer\":\"DNA samples from registered cases were sequenced and analyzed using Chromas software and bioinformatics tools including BLAT and RNAfold.\"},{\"question\":\"Which intronic CHEK2 variant was reported, and in how many cases?\",\"answer\":\"The intronic variant c.319+38-43dupA was identified, present in 9% of breast cancer cases and reported previously in non-Hodgkin lymphoma cases.\"}]","Predisposition of an Intronic Duplication in CHEK2 Gene in the Cases of Breast Cancer from Balochistan | PDF",13,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b10b3c10c7a75ba5dc8a306e8fc92772.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec622293b631944f784ac59837111cc6.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10819b7f03489e7a2d7d84fd3a26d761.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7072db4f9022fc6d3b183af7ece449f8.webp",980,1385]